表紙
市場調查報告書
商品編碼
1028895

全球結合型單株抗體市場報告:2021年版 - COVID-19擴大和2030年的變化

Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球結合型單株抗體市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 結合型單株抗體的市場特性

第3章 結合型單株抗體的市場趨勢與策略

第4章 COVID-19對結合型單株抗體的影響

第5章 結合型單株抗體的市場規模與成長

  • 全球結合型單株抗體市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球結合型單株抗體市場預測,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 結合型單株抗體市場區隔

  • 全球結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • Adcetris
  • Kadcyla
  • 全球結合型單株抗體市場,各技術市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 可切斷型連接試劑
  • 不可切斷型連接試劑
  • 全球結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 血液癌症
  • 乳癌
  • 卵巢癌
  • 肺癌
  • 腦瘤
  • 其他

第7章 結合型單株抗體市場各地區以及各國分析

  • 全球結合型單株抗體市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球結合型單株抗體市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的結合型單株抗體市場

  • 亞太地區的結合型單株抗體市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的結合型單株抗體市場

  • 中國的結合型單株抗體市場概要
  • 中國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的結合型單株抗體市場

  • 印度的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的結合型單株抗體市場

  • 日本的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 日本的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第12章 澳洲的結合型單株抗體市場

  • 澳洲的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的結合型單株抗體市場

  • 印尼的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的結合型單株抗體市場

  • 韓國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的結合型單株抗體市場

  • 西歐的結合型單株抗體市場概要
  • 西歐的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 西歐的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的結合型單株抗體市場

  • 英國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的結合型單株抗體市場

  • 德國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的結合型單株抗體市場

  • 法國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的結合型單株抗體市場

  • 東歐的結合型單株抗體市場概要
  • 東歐的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的結合型單株抗體市場

  • 俄羅斯的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的結合型單株抗體市場

  • 北美的結合型單株抗體市場概要
  • 北美的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的結合型單株抗體市場

  • 美國的結合型單株抗體市場概要
  • 美國的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的結合型單株抗體市場

  • 南美的結合型單株抗體市場概要
  • 南美的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 南美的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第24章 巴西的結合型單株抗體市場

  • 巴西的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的結合型單株抗體市場

  • 中東的結合型單株抗體市場概要
  • 中東的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的結合型單株抗體市場

  • 非洲的結合型單株抗體市場概要
  • 非洲的結合型單株抗體市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的結合型單株抗體市場,各用途市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 結合型單株抗體市場競爭情形和企業簡介

  • 結合型單株抗體市場競爭情形
  • 結合型單株抗體市場企業簡介
    • Pfizer Inc.
    • F. Hoffmann-LA
    • Bristol-Myers Squibb
    • Merck & Co. Inc.
    • Immunomedics Inc.

第28章 結合型單株抗體開發平台分析

第29章 結合型單株抗體市場上主要合併和收購

第30章 結合型單株抗體市場未來展望和潛在性分析

第31章 附錄

目錄
Product Code: h919

Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global conjugated monoclonal antibodies market.

This report focuses on conjugated monoclonal antibodies market which is experiencing strong growth. The report gives a guide to the conjugated monoclonal antibodies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the conjugated monoclonal antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Conjugated Monoclonal Antibodies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider conjugated monoclonal antibodies market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The conjugated monoclonal antibodies market section of the report gives context. It compares the conjugated monoclonal antibodies market with other segments of the conjugated monoclonal antibodies market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, conjugated monoclonal antibodies indicators comparison.

Scope

Markets Covered: 1) By Drugs: Adcetris; Kadcyla

2) By Technology: Cleavable Linker; Non-cleavable Linker

3) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumour; Others

Companies Mentioned: Pfizer Inc.; F. Hoffmann-LA; Bristol -Myers Squibb; Merck & Co. Inc.; Immunomedics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Conjugated Monoclonal Antibodies Market Characteristics

3. Conjugated Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Conjugated Monoclonal Antibodies

5. Conjugated Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Conjugated Monoclonal Antibodies Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Conjugated Monoclonal Antibodies Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Conjugated Monoclonal Antibodies Market Segmentation

  • 6.1. Global Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adcetris
  • Kadcyla
  • 6.2. Global Conjugated Monoclonal Antibodies Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cleavable Linker
  • Non-cleavable Linker
  • 6.3. Global Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumour
  • Others

7. Conjugated Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Conjugated Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Conjugated Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Conjugated Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Conjugated Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Conjugated Monoclonal Antibodies Market

  • 9.1. China Conjugated Monoclonal Antibodies Market Overview
  • 9.2. China Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Conjugated Monoclonal Antibodies Market

  • 10.1. India Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Conjugated Monoclonal Antibodies Market

  • 11.1. Japan Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Conjugated Monoclonal Antibodies Market

  • 12.1. Australia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Conjugated Monoclonal Antibodies Market

  • 13.1. Indonesia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Conjugated Monoclonal Antibodies Market

  • 14.1. South Korea Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Conjugated Monoclonal Antibodies Market

  • 15.1. Western Europe Conjugated Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Conjugated Monoclonal Antibodies Market

  • 16.1. UK Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Conjugated Monoclonal Antibodies Market

  • 17.1. Germany Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Conjugated Monoclonal Antibodies Market

  • 18.4. France Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Conjugated Monoclonal Antibodies Market

  • 19.1. Eastern Europe Conjugated Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Conjugated Monoclonal Antibodies Market

  • 20.1. Russia Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Conjugated Monoclonal Antibodies Market

  • 21.1. North America Conjugated Monoclonal Antibodies Market Overview
  • 21.2. North America Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Conjugated Monoclonal Antibodies Market

  • 22.1. USA Conjugated Monoclonal Antibodies Market Overview
  • 22.2. USA Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Conjugated Monoclonal Antibodies Market

  • 23.1. South America Conjugated Monoclonal Antibodies Market Overview
  • 23.2. South America Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Conjugated Monoclonal Antibodies Market

  • 24.1. Brazil Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Conjugated Monoclonal Antibodies Market

  • 25.1. Middle East Conjugated Monoclonal Antibodies Market Overview
  • 25.2. Middle East Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Conjugated Monoclonal Antibodies Market

  • 26.1. Africa Conjugated Monoclonal Antibodies Market Overview
  • 26.2. Africa Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Conjugated Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Conjugated Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Conjugated Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Pfizer Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. F. Hoffmann-LA
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol -Myers Squibb
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Merck & Co. Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Immunomedics Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Conjugated Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Conjugated Monoclonal Antibodies Market

30. Conjugated Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer